Alexander Nowakowski

7PUBLICATIONS
38CO-AUTHORS
Pharmaceutical delivery technologiesPredictive and prognostic markersMolecular targetsMetabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 12, 2026
A reversible broad-spectrum antiviral targets the human V-ATPase VO domain.

|Nov 26, 2025
Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis.

Matthew Dankner, Laurie-Rose Dubé, Mark Sorin

|Jan 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers.

Matthew Dankner, Emmanuelle Rousselle, Sarah Petrecca

|Dec 16, 2024
Machine learning prediction of brain metastasis invasion pattern on brain magnetic resonance imaging scans.

Keyhan Najafian, Benjamin Rehany, Alexander Nowakowski

|Nov 06, 2024
Mitochondrial elongation impairs breast cancer metastasis.

Lucía Minarrieta, Matthew G Annis, Yannick Audet-Delage

|Jan 25, 2024
Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes.

Matthew Dankner, Sarah M Maritan, Neibla Priego

Pageof 2

Frequent Collaborators

5 joint publications

Matthew Dankner

2 joint publications

Anna-Maria Lazaratos

1 joint publications

Manuel Valiente

1 joint publications

Lucía Minarrieta